Victoria E. Carr-Brendel, Ph.D.
Group Vice President (GVP) Cochlear Implants of Sonova and President of Advanced Bionics
Vicky joins Advanced Bionics, a Sonova Group, from JenaValve Technology Inc., a global and innovative transcatheter heart valve company, where she became CEO in mid-2015. She is an accomplished medical device executive with vast experience across several therapeutic areas. She started her career as a scientist in research and development and took on increasingly larger business roles throughout her career.
At JenaValve, she was responsible for bringing the company through new product development, clinical trial completion for CE mark, and optimizing the commercial launch of their next generation valve and system. Prior to her present position, she worked as Franchise General Manager at Boston Scientific, in the Peripheral Interventions division, where she ran global business operations, including the Bayer interventional radiology acquisition.
Vicky has a successful track record of growing businesses and improving profitability. Having spent her entire career in healthcare, she has a background as an innovation and growth leader, bringing with her marketing, development, clinical and strategic business experience in the medical device sector. She holds a Ph.D. in Microbiology and Immunology and she spent 18 years in various management roles.